ColoGuideEx receives attention

A prognostic test for colorectal cancer, developed by researchers at the Department of Cancer Prevention, receives attention from international researchers and from Norwegian media. The test, named ColoGuideEx, is a gene signature, where gene expression measurements from tumour tissue aid in prognostication of stage II colorectal cancer. The test was earlier this year published in the journal GUT.

uio.no, 16. juli 2012	forskning.no, 26. juli 2012
VG, 30. juli 2012	vg.no, 31. juli 2012
ColoGuideEx was highlighted in the lecture "Is gene signature based selection ready for clinical use?" by Pierre Laurent-Puig, MD, PhD, during the 14th world congress on Gastrointestinal cancer organized by The European Society of Medical Oncology in June.

Original scientific article:

Trude H. Ågesen, Anita Sveen, Marianne A. Merok, Guro E. Lind, Arild Nesbakken, Rolf I. Skotheim, and Ragnhild A. Lothe (2012). ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis. Gut [Epub ahead of print]